Clinical trial
Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
NCT00306683 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00306683 |
|---|---|
| Title | Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions |
| Official title | Clinical Assessment of the Treatment With Diazoxide in Children Suffering From Obesity and Hyperinsulinemia Secondary to Surgery of Hypothalamic-pituitary Lesions |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypothalamic-pituitary Lesions, Craniopharyngiomas |
| Intervention type | Drug |
| Interventions | DIAZOXIDE |
| Enrollment | 40 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Mar 24, 2006 |
| Last update posted | Feb 18, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: